ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 51 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,033,788 | +39.6% | 111,160 | +48.8% | 0.00% | – |
| Q1 2024 | $740,277 | +240.7% | 74,700 | +11.1% | 0.00% | – |
| Q4 2023 | $217,250 | -43.5% | 67,260 | -7.0% | 0.00% | – |
| Q3 2023 | $384,232 | -49.6% | 72,360 | -9.6% | 0.00% | – |
| Q2 2023 | $762,686 | -53.3% | 80,030 | -46.1% | 0.00% | -100.0% |
| Q1 2023 | $1,633,500 | +186.7% | 148,500 | +285.7% | 0.00% | – |
| Q4 2022 | $569,800 | +5.3% | 38,500 | +36.0% | 0.00% | – |
| Q3 2022 | $541,000 | -10.3% | 28,300 | 0.0% | 0.00% | – |
| Q2 2022 | $603,000 | +54.2% | 28,300 | +39.4% | 0.00% | – |
| Q1 2022 | $391,000 | -7.1% | 20,300 | 0.0% | 0.00% | – |
| Q4 2021 | $421,000 | -6.2% | 20,300 | +8.0% | 0.00% | – |
| Q3 2021 | $449,000 | -12.5% | 18,800 | 0.0% | 0.00% | – |
| Q2 2021 | $513,000 | +29.5% | 18,800 | +37.2% | 0.00% | – |
| Q1 2021 | $396,000 | -10.8% | 13,700 | -13.3% | 0.00% | – |
| Q4 2020 | $444,000 | -80.0% | 15,800 | -79.1% | 0.00% | -100.0% |
| Q3 2020 | $2,217,000 | -5.2% | 75,664 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $2,339,000 | +14.0% | 77,364 | +12.4% | 0.00% | 0.0% |
| Q1 2020 | $2,051,000 | – | 68,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $128,526,634 | 7.99% |
| Saturn V Capital Management LP | 487,179 | $8,787,113 | 7.29% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $44,400 | 4.96% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $8,421,807 | 3.66% |
| Logos Global Management LP | 1,400,000 | $20,720,000 | 2.43% |
| Rubric Capital Management LP | 2,742,519 | $40,589,281 | 1.77% |
| 1492 Capital Management LLC | 174,546 | $2,583,281 | 1.67% |
| AlphaCentric Advisors LLC | 78,500 | $1,161,800 | 1.15% |
| MPM BioImpact LLC | 262,069 | $3,878,621 | 1.01% |
| Orbimed Advisors | 2,460,108 | $36,409,598 | 0.70% |